Global Prostate Cancer Nuclear Medicine Diagnostics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size 2017-2028

2.1.2 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Prostate Cancer Nuclear Medicine Diagnostics Segment by Type

2.2.1 SPECT

2.2.2 PET

2.3 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type

2.3.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2022)

2.4 Prostate Cancer Nuclear Medicine Diagnostics Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application

2.5.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2022)

3 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Player

3.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Players

3.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2020-2022)

3.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Players (2020-2022)

3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Prostate Cancer Nuclear Medicine Diagnostics by Regions

4.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions (2017-2022)

4.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2017-2022)

4.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2017-2022)

4.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2017-2022)

4.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)

5.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)

5.3 Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022)

6.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)

6.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Prostate Cancer Nuclear Medicine Diagnostics by Country (2017-2022)

7.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)

7.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics by Region (2017-2022)

8.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)

8.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.1 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Regions (2023-2028)

10.1.1 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Regions (2023-2028)

10.1.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Forecast

10.1.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Forecast

10.1.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Forecast

10.1.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Forecast

10.2 Americas Prostate Cancer Nuclear Medicine Diagnostics Forecast by Country (2023-2028)

10.2.1 United States Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.2.2 Canada Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.2.3 Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.2.4 Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Forecast by Region (2023-2028)

10.3.1 China Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.3.2 Japan Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.3.3 Korea Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.3.4 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.3.5 India Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.3.6 Australia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Forecast by Country (2023-2028)

10.4.1 Germany Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.4.2 France Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.4.3 UK Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.4.4 Italy Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.4.5 Russia Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.5 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Forecast by Region (2023-2028)

10.5.1 Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.5.2 South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.5.3 Israel Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.5.4 Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.5.5 GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Market Forecast

10.6 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Type (2023-2028)

10.7 Global Prostate Cancer Nuclear Medicine Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Blue Earth Diagnostics

11.1.1 Blue Earth Diagnostics Company Information

11.1.2 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Blue Earth Diagnostics Main Business Overview

11.1.5 Blue Earth Diagnostics Latest Developments

11.2 PETNET Solutions

11.2.1 PETNET Solutions Company Information

11.2.2 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 PETNET Solutions Main Business Overview

11.2.5 PETNET Solutions Latest Developments

11.3 Cardinal Health

11.3.1 Cardinal Health Company Information

11.3.2 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Cardinal Health Main Business Overview

11.3.5 Cardinal Health Latest Developments

11.4 Lantheus Medical Imaging

11.4.1 Lantheus Medical Imaging Company Information

11.4.2 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Lantheus Medical Imaging Main Business Overview

11.4.5 Lantheus Medical Imaging Latest Developments

11.5 Jubilant Pharma

11.5.1 Jubilant Pharma Company Information

11.5.2 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Jubilant Pharma Main Business Overview

11.5.5 Jubilant Pharma Latest Developments

11.6 NCM-USA

11.6.1 NCM-USA Company Information

11.6.2 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 NCM-USA Main Business Overview

11.6.5 NCM-USA Latest Developments

11.7 Progenics Pharma

11.7.1 Progenics Pharma Company Information

11.7.2 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Progenics Pharma Main Business Overview

11.7.5 Progenics Pharma Latest Developments

11.8 Telix Pharma

11.8.1 Telix Pharma Company Information

11.8.2 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Telix Pharma Main Business Overview

11.8.5 Telix Pharma Latest Developments

11.9 ImaginAb

11.9.1 ImaginAb Company Information

11.9.2 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 ImaginAb Main Business Overview

11.9.5 ImaginAb Latest Developments

11.10 Theragnostics

11.10.1 Theragnostics Company Information

11.10.2 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Theragnostics Main Business Overview

11.10.5 Theragnostics Latest Developments

11.11 Novartis

11.11.1 Novartis Company Information

11.11.2 Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Novartis Main Business Overview

11.11.5 Novartis Latest Developments

11.12 Alliance Medical

11.12.1 Alliance Medical Company Information

11.12.2 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Offered

11.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Alliance Medical Main Business Overview

11.12.5 Alliance Medical Latest Developments

12 Research Findings and Conclusion

Table 1. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of SPECT

Table 3. Major Players of PET

Table 4. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2022)

Table 7. Prostate Cancer Nuclear Medicine Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2022)

Table 10. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Player (2020-2022)

Table 12. Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Products Offered

Table 13. Prostate Cancer Nuclear Medicine Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Regions (2017-2022)

Table 18. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country (2017-2022)

Table 20. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2022)

Table 22. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2022)

Table 24. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region (2017-2022)

Table 26. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2022)

Table 28. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2022)

Table 30. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country (2017-2022)

Table 32. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2022)

Table 34. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Prostate Cancer Nuclear Medicine Diagnostics

Table 43. Key Market Challenges & Risks of Prostate Cancer Nuclear Medicine Diagnostics

Table 44. Key Industry Trends of Prostate Cancer Nuclear Medicine Diagnostics

Table 45. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share Forecast by Application (2023-2028)

Table 51. Blue Earth Diagnostics Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 52. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 53. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Blue Earth Diagnostics Main Business

Table 55. Blue Earth Diagnostics Latest Developments

Table 56. PETNET Solutions Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 57. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 58. PETNET Solutions Main Business

Table 59. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. PETNET Solutions Latest Developments

Table 61. Cardinal Health Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 62. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 63. Cardinal Health Main Business

Table 64. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Cardinal Health Latest Developments

Table 66. Lantheus Medical Imaging Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 67. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 68. Lantheus Medical Imaging Main Business

Table 69. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Lantheus Medical Imaging Latest Developments

Table 71. Jubilant Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 72. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 73. Jubilant Pharma Main Business

Table 74. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Jubilant Pharma Latest Developments

Table 76. NCM-USA Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 77. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 78. NCM-USA Main Business

Table 79. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. NCM-USA Latest Developments

Table 81. Progenics Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 82. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 83. Progenics Pharma Main Business

Table 84. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Progenics Pharma Latest Developments

Table 86. Telix Pharma Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 87. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 88. Telix Pharma Main Business

Table 89. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Telix Pharma Latest Developments

Table 91. ImaginAb Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 92. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 93. ImaginAb Main Business

Table 94. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. ImaginAb Latest Developments

Table 96. Theragnostics Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 97. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 98. Theragnostics Main Business

Table 99. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Theragnostics Latest Developments

Table 101. Novartis Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 102. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 103. Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Novartis Main Business

Table 105. Novartis Latest Developments

Table 106. Alliance Medical Details, Company Type, Prostate Cancer Nuclear Medicine Diagnostics Area Served and Its Competitors

Table 107. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Offered

Table 108. Alliance Medical Main Business

Table 109. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Alliance Medical Latest Developments

List of Figures

Figure 1. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type in 2021

Figure 7. Prostate Cancer Nuclear Medicine Diagnostics in Hospitals

Figure 8. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Prostate Cancer Nuclear Medicine Diagnostics in Clinics

Figure 10. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Prostate Cancer Nuclear Medicine Diagnostics in Others

Figure 12. Global Prostate Cancer Nuclear Medicine Diagnostics Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2021

Figure 14. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Player in 2021

Figure 15. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Prostate Cancer Nuclear Medicine Diagnostics Value Market Share by Country in 2021

Figure 21. Americas Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Share by Type in 2021

Figure 22. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2021

Figure 23. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region in 2021

Figure 28. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2021

Figure 29. China Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Country in 2021

Figure 36. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type in 2021

Figure 37. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2021

Figure 38. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application in 2021

Figure 46. Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 55. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 59. China Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 63. India Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 66. France Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 67. UK Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size 2023-2028 ($ Millions)